Tucson’s Critical Path Institute (C-Path) is expanding its national presence, opening up offices in Phoenix and Washington, D.C.
Jeffrey Cossman, an internationally recognized expert in molecular pathology, has been hired as C-Path’s chief scientific officer. He will help set up a C-Path office in Washington, D.C., to increase the institute’s collaboration with the Food and Drug Administration, a founding partner of C-Path.
Ellen Feigal, vice president of clinical sciences at the Translational Genomics Research Institute (TGen), will take a sabbatical to lead C-Path’s Phoenix office.
Jeffrey Trent, president and scientific director of TGen, told the Business Journal that Feigal’s appointment will continue the collaboration that has been the hallmark of Arizona’s growing bioscience industry.
“We see this as a tremendous opportunity to strategically align TGen science with C-Path’s mission to bring faster, smarter, and safer medical interventions to applications and medical care,” Trent said.
C-Path will temporarily be housed at Phoenix law firm Snell & Wilmer. Feigal told the Business Journal that she will look for permanent space near the Phoenix Biomedical Campus at Seventh and Van Buren streets, where TGen and the Phoenix campus of the University of Arizona medical school are located.
For more information:
“Drug research institute opens Phoenix, D.C. offices,” Business Journal, 04/21/2006